Double Medical Technology Inc

002901 · SHE · Healthcare / Medical Devices

40.68CNY+0.10 (+0.25%)

Price History

Full chart

Market Stats

Previous Close40.58

Open40.67

Day Range40.30 – 41.36

52-Week Range38.50 – 59.21

Volume1.48M

Market Cap16.93B

P/E (TTM)23.63

Forward P/E0.00

EPS1.73

Dividend Yield1.48%

Beta0.06

50-Day Avg42.63

200-Day Avg44.52

About

Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was incorporated in 2004 and is headquartered in Xiamen, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMs. Danhe Chen
Employees4.70K
HeadquartersNo. 18, Hongdong Road, Xiamen, China, 361027, China
Websitehttps://www.double-medical.com

Leadership

Ms. Danhe ChenFinancial Director & Accounting Supervisor · b. 1980
Mr. Xiannan HuaBoard Secretary · b. 1983
Mr. You Cun ChenDeputy General Manager

Financials

Income Statement

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	202.66M	298.89M	391.83M	462.66M	594.01M	772.47M	1.26B	1.59B	1.99B	1.43B	1.53B	2.14B	2.60B
Growth (%)	-	+47.49%	+31.09%	+18.08%	+28.39%	+30.04%	+62.77%	+26.21%	+25.68%	-28.09%	+6.90%	+39.29%	+21.79%
Cost of Revenue	41.98M	60.34M	76.28M	84.58M	102.84M	153.99M	184.41M	230.65M	319.12M	344.60M	541.52M	710.15M	767.19M
Gross Profit	160.67M	238.55M	315.55M	378.08M	491.17M	618.48M	1.07B	1.36B	1.68B	1.09B	991.60M	1.43B	1.83B
Gross Margin	79.28%	79.81%	80.53%	81.72%	82.69%	80.07%	85.33%	85.46%	84.00%	75.97%	64.68%	66.75%	70.50%
Operating Expense	51.78M	78.87M	101.48M	135.02M	140.25M	177.69M	501.91M	641.47M	853.21M	942.04M	888.39M	995.85M	1.11B
Operating Income	108.89M	159.68M	214.07M	243.07M	350.93M	440.79M	571.00M	714.74M	822.01M	147.45M	103.22M	429.56M	719.07M
Operating Margin	53.73%	53.42%	54.64%	52.54%	59.08%	57.06%	45.41%	45.04%	41.22%	10.28%	6.73%	20.11%	27.65%
EBITDA	107.34M	170.92M	229.78M	259.83M	339.83M	435.49M	529.66M	683.41M	782.07M	117.12M	121.28M	446.79M	872.86M
EBITDA Margin	52.97%	57.18%	58.64%	56.16%	57.21%	56.38%	42.13%	43.07%	39.21%	8.17%	7.91%	20.92%	33.56%
Net Income	96.81M	139.29M	188.67M	219.33M	295.56M	371.45M	465.49M	605.68M	673.31M	92.56M	58.96M	356.80M	599.63M
Net Income Margin	47.77%	46.60%	48.15%	47.41%	49.76%	48.09%	37.02%	38.17%	33.76%	6.45%	3.85%	16.71%	23.06%
R&D	-	23.80M	35.78M	39.96M	53.66M	64.81M	100.38M	128.02M	167.07M	256.72M	285.28M	306.87M	331.20M
R&D as % of Total Revenue	-	7.96%	9.13%	8.64%	9.03%	8.39%	7.98%	8.07%	8.38%	17.90%	18.61%	14.37%	12.73%
Interest Expense	463.60K	854.06K	686.21K	101.89K	78.31K	115.61K	92.10K	142.73K	747.33K	3.42M	7.49M	6.86M	6.18M
Interest Expense % of Total Revenue	0.23%	0.29%	0.18%	0.02%	0.01%	0.01%	0.01%	0.01%	0.04%	0.24%	0.49%	0.32%	0.24%

Balance Sheet

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	296.19M	545.28M	561.32M	719.06M	1.39B	1.67B	2.24B	2.65B	3.38B	3.94B	4.64B	4.42B	4.92B
Total Liabilities	71.58M	270.92M	119.54M	138.93M	149.80M	207.22M	485.31M	511.72M	791.47M	831.15M	1.48B	1.24B	1.24B
Total Equity	224.13M	271.24M	439.10M	573.90M	1.23B	1.44B	1.72B	2.10B	2.51B	3.00B	3.06B	3.08B	3.57B
Cash	36.93M	99.13M	36.03M	62.60M	512.87M	830.45M	764.57M	562.88M	410.19M	992.67M	1.23B	1.08B	1.22B
Total Debt	-	18.00M	-	-	4.50M	-	-	3.90M	13.61M	60.86M	588.33M	328.35M	-
Net Debt	-36.93M	-81.13M	-36.03M	-62.60M	-512.87M	-830.45M	-764.57M	-558.98M	-396.58M	-931.81M	-639.54M	-747.59M	-

Cash Flow

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	106.51M	151.12M	123.44M	207.13M	308.70M	334.88M	433.88M	555.77M	673.26M	128.44M	73.89M	442.30M	831.34M
Investing Cash Flow	-51.60M	-138.10M	-137.19M	-141.62M	-541.71M	-263.65M	-268.98M	-276.12M	-396.76M	-225.61M	-508.01M	153.60M	-
Financing Cash Flow	-7.29M	28.69M	-51.01M	-58.12M	330.16M	-137.17M	-198.94M	-255.64M	-259.33M	245.16M	496.20M	-617.20M	-
Capital Expenditure	29.46M	80.74M	76.53M	33.35M	36.89M	103.38M	319.29M	137.13M	235.11M	285.07M	305.72M	270.46M	133.51M
Free Cash Flow	77.05M	70.38M	46.91M	173.78M	271.81M	231.50M	114.59M	418.64M	438.15M	-156.63M	-231.82M	171.84M	697.83M
Dividends Paid	33.00K	4.71M	73.52M	58.14M	96.06M	160.04M	206.87M	241.34M	324.11M	208.46M	9.43M	118.07M	214.36M
FCF to OCF	72.34%	46.57%	38.00%	83.90%	88.05%	69.13%	26.41%	75.33%	65.08%	-121.94%	-313.73%	38.85%	83.94%
Dividend Paid to FCF	0.04%	6.69%	156.73%	33.46%	35.34%	69.13%	180.53%	57.65%	73.97%	-133.09%	-4.07%	68.71%	30.72%

Earnings

Report Date	Oct 26, 2017	Feb 1, 2018	Apr 30, 2018	Aug 21, 2018	Oct 25, 2018	Jan 29, 2019	Apr 26, 2019	Aug 20, 2019	Oct 29, 2019	Feb 27, 2020	Apr 24, 2020	Aug 28, 2020	Oct 22, 2020	Apr 26, 2021	Aug 25, 2021	Oct 25, 2021	Mar 29, 2022	Apr 15, 2022	Aug 23, 2022	Oct 27, 2022	Apr 28, 2023	Aug 30, 2023	Oct 26, 2023	Mar 29, 2024	Apr 29, 2024	Aug 28, 2024	Oct 31, 2024	Apr 29, 2025	Aug 25, 2025	Oct 29, 2025	May 1, 2026	Aug 27, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.20	0.21	0.17	0.27	0.27	0.22	0.21	0.31	0.34	0.30	0.22	0.44	0.41	0.45	0.45	0.35	0.54	0.27	0.17	0.08	-0.28	0.09	0.01	-0.09	-0.09	0.18	0.25	0.28	0.35	0.44	0.36	0.50
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	After-hours	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	After-hours	Pre-market	-	Pre-market	-	-	-	-

Key Statistics & Ratios

Market Cap16.93B

Enterprise Value15.83B

Trailing P/E23.63

Forward P/E0.00

Price / Sales6.20

Price / Book4.91

EPS1.73

Book Value8.70

Revenue (TTM)2.73B

Gross Profit (TTM)1.91B

EBITDA787.03M

Profit Margin25.96%

Operating Margin23.64%

Return on Equity22.09%

Return on Assets8.70%

Shares Outstanding414.02M

Shares Float63.46M

Beta0.06

Dividend Yield1.48%

Dividend Rate0.60

Payout Ratio45.98%

Dividends

20261×

0.60Jul 7, 2026

20251×

0.50May 30, 2025

20241×

0.25Jun 24, 2024

20221×

0.50May 9, 2022

20211×

0.80Jul 1, 2021

20201×

0.60Jul 13, 2020

20191×

0.50Jun 18, 2019

20181×

0.40Jun 15, 2018